Bright dyes help resolve rare and dim cell populations
THE journal OF Immunology
BD Horizon™ Brilliant Violet™ Polymer Conjugates
VOL. 191 | NO. 1 | July 1, 2013 | Pages 1–522
For more discerning research.
Now you can resolve rare or dim cell populations
with BD Horizon™ Brilliant Violet™ polymer
conjugates from BD Biosciences.
Developed from pioneering polymer dye
technology acquired from Sirigen Ltd.,
BD Horizon Brilliant Violet dyes are brighter
than conventional dyes. Improved brightness
enables you to identify cell populations
with lower receptor density than was
previously possible, resolving cell populations
previously obscured.
The complete portfolio of BD conjugated
antibodies can be used to explore cellular
features and characterize cells through surface,
intracellular, or secreted markers. To ensure you
can use BD reagents across your entire multicolor
panel, our portfolio contains a broad selection of
fluorochrome-conjugated antibodies.
Request a free sample, or find out how you
can use BD Horizon Brilliant Violet polymer
conjugates with our expanded set of tools and
information at bdbiosciences.com/go/brilliant.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2013 BD
23-14921-00
BD Biosciences
2350 Qume Drive
San Jose, CA 95131
bdbiosciences.com
The
Journal of
Immunology
V O L U M E 1 9 1 , N U M B E R 1 • J U LY 1 , 2 0 1 3 • W W W. J I M M U N O L . O R G
Postdoctoral Fellowship Position Available
The Division of Rheumatology, Immunology and Allergy at the
Brigham and Women’s Hospital in Boston, Massachusetts
is offering a postdoctoral research fellowship within the
divisional 6ection of Research in InÀammation and Allergic
Disease. The studies will focus on the mechanisms of
cross-talk between purinergic receptors and the receptors
for cysteinyl leukotrienes using both in vitro and in vivo
approaches. A wide array of resources, including transgenic
mice, antibodies, and equipment is available for these
studies. The Hospital is a maMor teaching af¿liate of the
Harvard Medical School. Candidates with Ph.D. or M.D./
Ph.D. degrees with backgrounds in molecular biology,
immunology, genetics, and proteomics are highly desirable.
Experience with animal models preferred. Interested
candidates should provide a CV and letters of reference to
Joshua A. Boyce, M.D., at [email protected],
Smith Research Building, One Jimmy Fund Way, Boston,
MA 02115.
Harvard Medical School and Brigham and Women’s Hospital are Equal Opportunity/
$I¿rmative $ction Employers Women and minority candidates are particularly encouraged
to apply
AAI Courses in Immunology
2013 Introductory Course in Immunology
July 13–18, 2013
The University of Pennsylvania, Philadelphia, Pennsylvania
Director: Michael P. Cancro, Ph.D.
University of Pennsylvania, Perelman School of Medicine
Co-Director: Christopher A. Hunter, Ph.D.
University of Pennsylvania School of Veterinary Medicine
2013 Advanced Course in Immunology
July 28–August 2, 2013
Seaport World Trade Center, Boston, Massachusetts
Course Director: Leslie J. Berg, Ph.D.
University of Massachusetts Medical School
For complete course details and registration, visit: www.aai.org/Education/Courses
For assistance, contact (301) 634-7178 or [email protected].